Matrix Partners China and SAIF Partners have led a RMB100 million (US$14 million) series A funding round in GrandOmics, a Beijing-based biomedical and genetic testing start-up, according to an announcement.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription? Log in
